How To Repurpose Video Content for Bigger and Better Results
Video is a necessity in your marketing strategy now, given that people now watch more
Results
Getting First-Class Results on a Coach Budget
guest blog by Eric Alzuhn, Dialsmith You’re feeling it too, right? Everything costs more. From travel to
Stealth BioTherapeutics Reports Fiscal Year 2020 Financial Results And Recent Business Highlights
BOSTON, April 6, 2021 /PRNewswire/ — Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused
E2open Announces Business Update and Provides Preliminary Financial Results
AUSTIN, Texas–(BUSINESS WIRE)–Apr 5, 2021– E2open (NYSE: ETWO), a leading network-based provider of 100{f13b67734a7459ff15bce07f17c500e58f5449212eae0f7769c5b6fbcf4cc0c4} cloud-based,
Bolt Biotherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
– Upsized IPO in February 2021 raised $264.5 million in gross proceeds plus Series C
BiomX Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
NESS ZIONA, Israel–(BUSINESS WIRE)–Mar 31, 2021– BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”),
XpresSpa Group Provides Business Update and Announces Fourth Quarter 2020 Financial Results
Eleven XpresCheck Wellness Centers Currently Operating with Two Additional Locations to Open Soon Positioned to
AgeX Therapeutics Reports Fourth Quarter and Annual 2020 Financial Results and Provides Business Update
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for
Frequency Therapeutics Supplies Enterprise Updates and Reports Fourth Quarter and Full Year 2020 Fiscal Results
WOBURN, Mass.–(Enterprise WIRE)–Mar 29, 2021– Frequency Therapeutics, Inc. (Nasdaq: FREQ), a medical-stage biotechnology organization concentrated
I-Mab Reports Financial Results for Full Year of 2020 and Provides Business Updates
18 significant clinical milestones achieved since the Company’s IPO in January 2020, with multiple important
Enterprise alumna supports learners, credits UTSA for occupation good results | UTSA These days | UTSA
Just this earlier calendar year she decided to set up a $250,000 reward in her
Harmony Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Business Updates
WAKIX® (pitolisant) Total Revenue of $160 Million for Full-Year 2020; $56 Million for Fourth Quarter
Evolus Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update
Q4 2020 Net Revenue $20.6 Million, Highest Net Revenue Quarter Since Launch of Jeuveau® Pro
Celyad Oncology Reports Full Year 2020 Financial Results and Recent Business Highlights
No safety concerns or evidence of Graft-versus-Host disease reported from first dose cohort of Phase
Sana Biotechnology Reports Fourth Quarter and 2020 Financial Results and Business Updates
Expects to present data at multiple scientific conferences in 2021 2020 year-end cash position of
VISIATIV – 2020 annual results: Visiativ’s solid business model driven by recurring revenues – 24/03/2021 – 18H00
Limited drop of 7{f13b67734a7459ff15bce07f17c500e58f5449212eae0f7769c5b6fbcf4cc0c4} in activity, with recurring revenues up 5{f13b67734a7459ff15bce07f17c500e58f5449212eae0f7769c5b6fbcf4cc0c4} to 70{f13b67734a7459ff15bce07f17c500e58f5449212eae0f7769c5b6fbcf4cc0c4} of the
Aligos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
– Advanced ALG-010133 and ALG-000184 into the clinic – both expected to generate safety and
Newtek Business Services Corp. Reports Full Year 2020 Financial Results
BOCA RATON, Fla., March 22, 2021 (GLOBE NEWSWIRE) — Newtek Business Services Corp. (“Newtek” or